These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12724567)

  • 1. Morphometry of canine cutaneous mast cell tumors.
    Strefezzi Rde F; Xavier JG; Catão-Dias JL
    Vet Pathol; 2003 May; 40(3):268-75. PubMed ID: 12724567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleomorphometric analysis of canine cutaneous mast cell tumours.
    Maiolino P; Cataldi M; Paciello O; Restucci B; De Vico G
    J Comp Pathol; 2005; 133(2-3):209-11. PubMed ID: 16045919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs.
    Abadie JJ; Amardeilh MA; Delverdier ME
    J Am Vet Med Assoc; 1999 Dec; 215(11):1629-34. PubMed ID: 14567425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the KIT protein (CD117) in primary cutaneous mast cell tumors of the dog.
    Preziosi R; Morini M; Sarli G
    J Vet Diagn Invest; 2004 Nov; 16(6):554-61. PubMed ID: 15586571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a two-centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs.
    Fulcher RP; Ludwig LL; Bergman PJ; Newman SJ; Simpson AM; Patnaik AK
    J Am Vet Med Assoc; 2006 Jan; 228(2):210-5. PubMed ID: 16426187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical and clinical evaluation of p53 in canine cutaneous mast cell tumors.
    Jaffe MH; Hosgood G; Taylor HW; Kerwin SC; Hedlund CS; Lopez MK; Davidson JR; Miller DM; Paranjpe M
    Vet Pathol; 2000 Jan; 37(1):40-6. PubMed ID: 10643979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of canine mast cell tumors for presence of estrogen receptors.
    Larsen AE; Grier RL
    Am J Vet Res; 1989 Oct; 50(10):1779-80. PubMed ID: 2508516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of serotonin and its 5-HT1A receptor in canine cutaneous mast cell tumours.
    Fröberg GK; Lindberg R; Ritter M; Nordlind K
    J Comp Pathol; 2009; 141(2-3):89-97. PubMed ID: 19446835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical detection of p53 tumor-suppressor protein is a poor indicator of prognosis for canine cutaneous mast cell tumors.
    Ginn PE; Fox LE; Brower JC; Gaskin A; Kurzman ID; Kubilis PS
    Vet Pathol; 2000 Jan; 37(1):33-9. PubMed ID: 10643978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs.
    Patnaik AK; Ehler WJ; MacEwen EG
    Vet Pathol; 1984 Sep; 21(5):469-74. PubMed ID: 6435301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of intratumoral vessel density in cutaneous mast cell tumors of the dog.
    Preziosi R; Sarli G; Paltrinieri M
    J Comp Pathol; 2004; 130(2-3):143-51. PubMed ID: 15003472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours.
    Kiupel M; Webster JD; Miller RA; Kaneene JB
    J Vet Med A Physiol Pathol Clin Med; 2005 Aug; 52(6):280-6. PubMed ID: 16050909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is your diagnosis? Mast cell sarcoma.
    Dunn K
    J Small Anim Pract; 1997 Mar; 38(3):93, 108. PubMed ID: 9097238
    [No Abstract]   [Full Text] [Related]  

  • 14. Ultrastructure of canine, feline, and bovine mast cell neoplasms.
    Madewell BR; Munn RJ; Phillips LK
    Am J Vet Res; 1984 Oct; 45(10):2066-73. PubMed ID: 6437300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors for radiation treatment of mast cell tumor in 85 dogs.
    Turrel JM; Kitchell BE; Miller LM; Théon A
    J Am Vet Med Assoc; 1988 Oct; 193(8):936-40. PubMed ID: 3142828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Debate on grade-III mast cell tumors continues.
    Koltveit AJ
    J Am Vet Med Assoc; 2004 Apr; 224(7):1071. PubMed ID: 15074849
    [No Abstract]   [Full Text] [Related]  

  • 17. Questions data supporting conclusions on grade-III mast cell tumors.
    Schulman FY; Lipscomb TP
    J Am Vet Med Assoc; 2004 Feb; 224(4):501; author reply 501. PubMed ID: 14989538
    [No Abstract]   [Full Text] [Related]  

  • 18. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.
    Vascellari M; Giantin M; Capello K; Carminato A; Morello EM; Vercelli A; Granato A; Buracco P; Dacasto M; Mutinelli F
    Vet Pathol; 2013 Jan; 50(1):110-21. PubMed ID: 22673539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Electron microscopy demonstration of sulphurated acid mucopolysaccharides in canine mast cell tumors, using barium chloride and ruthenium red, together with comments on the classification and differentiation of tumor cells].
    Rudolph R
    Arch Exp Veterinarmed; 1971; 25(6):925-35. PubMed ID: 4113751
    [No Abstract]   [Full Text] [Related]  

  • 20. Association of histologic tumor characteristics and size of surgical margins with clinical outcome after surgical removal of cutaneous mast cell tumors in dogs.
    Schultheiss PC; Gardiner DW; Rao S; Olea-Popelka F; Tuohy JL
    J Am Vet Med Assoc; 2011 Jun; 238(11):1464-9. PubMed ID: 21627510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.